BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24419747)

  • 1. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function.
    Bove M; Cicero AFG; Borghi C
    Curr Hypertens Rep; 2017 Oct; 19(12):95. PubMed ID: 29071435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?
    Nashar K; Fried LF
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):386-91. PubMed ID: 23089273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
    Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum urate: a biomarker or treatment target in pediatric hypertension?
    Yanik M; Feig DI
    Curr Opin Cardiol; 2013 Jul; 28(4):433-8. PubMed ID: 23736817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and the development of hypertension.
    Hwu CM; Lin KH
    Med Sci Monit; 2010 Oct; 16(10):RA224-30. PubMed ID: 20885365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia and hypertension.
    Feig DI
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):377-85. PubMed ID: 23089272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid lowering therapy in cardiovascular diseases.
    Volterrani M; Iellamo F; Sposato B; Romeo F
    Int J Cardiol; 2016 Jun; 213():20-2. PubMed ID: 26386814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Feig DI
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):526-30. PubMed ID: 19654543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid in hypertension and renal disease: the chicken or the egg?
    Kanbay M; Solak Y; Dogan E; Lanaspa MA; Covic A
    Blood Purif; 2010; 30(4):288-95. PubMed ID: 21088389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperuricemia and the problem of chronic kidney disease].
    Shcherbak AV; Kozlovskaia LV; Bobkova IN; Balkarov IM; Lebedeva MV; Stakhova TIu
    Ter Arkh; 2013; 85(6):100-4. PubMed ID: 23875201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
    Bove M; Cicero AF; Veronesi M; Borghi C
    Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid--a uremic toxin?
    Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
    Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.